⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
Form 8-K
sec.gov
QNCX
GSK
AZN
ZYME
TNYA
NTAP
EXEL
NVS
KLRS
NKTX
CLYM
INSM
France Radiopharmaceuticals and Theranostics Market Size, Trends, and Forecast to 2035 | Market to Reach $1.03 Billion as Radioligand Therapy and Isotope Capacity Expands
globenewswire.com
NVS
CAH
Europe CAR-T Therapies Market for Autoimmune Disorders: Trends, Growth, and Forecast to 2035 | 47.4% CAGR Signals a USD 1.25 Billion Opportunity as Clinical Pipelines Advance
globenewswire.com
AUTL
KYMR
NVS
SANA
JNJ
Targeted Cancer Therapy Market Size and Forecast by Therapy Type, Disease Indication, End-User, and Region, 2026-2035 | Precision Oncology Drives 6.8% CAGR Toward $175.48 Billion
globenewswire.com
AZN
NVS
Europe Alpha-Emitting Radioligand Therapy Market Trends and Forecast to 2035 | 26% CAGR Drives Market Toward USD 0.40 Billion as Isotope Capacity and Oncology Pipelines Expand
globenewswire.com
NVS
LLY
BMY
Europe Cancer Metabolism Based Therapeutics Market Forecast to 2035 by Modality, Route, Indication, and Therapy Sales | 25.3% CAGR Drives an $8.54 Billion Opportunity
globenewswire.com
AZN
NVS
ROG
Autoimmune CAR T Safety Events Reshape Rheumatologist Sentiment, but Autologous CAR T Retains Lead, According to Spherix Global Insights
globenewswire.com
NVS
BMY
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
prnewswire.com
NVS
American Kidney Fund and IgA Nephropathy Foundation Advocate on Capitol Hill for Rare Kidney Disease Legislation
globenewswire.com
AMGN
VRTX
NVS
Atherosclerotic Cardiovascular Disease (ASCVD) Market Insights, Epidemiology, and Forecast - 2036 | 7MM Market to Reach USD 40 Billion as Precision Therapies Reshape Growth
globenewswire.com
AMGN
ARWR
NVS
ALNY
SNY
REGN
ESPR
JNJ
AZN
AMRN
MRK
LLY
BMY
ON
NVO